A synthetic pentadecapeptide derived from human gastric juice, studied for its regenerative and protective properties.
World journal of gastroenterology|2004|Xue X et al.
AIM: To investigate the protective effects of gastric pentadecapeptide BPC 157 on acute and chronic gastric ulcers in rats and to compare the results in therapy of human gastric ulcers by different administration methods. METHODS: Gastric pentadecape…
Animal Study
PMID: 15052688
Journal of orthopaedic research : official publication of the Orthopaedic Research Society|2003|Staresinic M et al.
In studies intended to improve healing of transected Achilles tendon, effective was a stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419). Currently in clinical trials for inflammatory bowel disease (PLD-116, PL 14736, Pliva), it ame…
Animal StudyIn Vitro
PMID: 14554208
European journal of pharmacology|2003|Bedekovic V et al.
The focus was on salivary glands in cysteamine-induced duodenal ulcer and the different effects of antiulcer agents on cysteamine-induced duodenal ulcer in sialoadenectomized but not gastrectomized rats. We tested antiulcer agents on cysteamine-induc…
Animal Study
PMID: 14512101
Burns : journal of the International Society for Burn Injuries|2003|Sikiric P et al.
The amelioration of corticosteroid-impairment of healing by a stable gastric pentadecapeptide BPC-157 (GEPPPGKPADDAGLV, M(w) 1419, currently in early clinical trials for inflammatory bowel disease) was studied in thermally injured mice. Its effects o…
Animal StudyIn Vitro
PMID: 12781609
Acta pharmacologica Sinica|2002|Sikiric P et al.
AIM: To investigate the effect of pentadecapeptide BPC 157 on chronic exposure to amphetamine in rats, particularly the changes commonly referred in chronic amphetamine studies as tolerance (lesser grade of stereotyped behavior, without increased exc…
Animal Study
PMID: 11978191
Journal of physiology, Paris|2001|Stancic-Rokotov D et al.
Anti-ulcer agents may likely attenuate lesions outside the gastrointestinal tract, since they had protected gastrectomized rats (a "direct cytoprotective effect"). Therefore, their therapeutic potential in lung/stomach lesions were shown. Rats receiv…
Animal Study
PMID: 11595454
Journal of physiology, Paris|2001|Prkacin I et al.
Unlike severe gastric damage acutely induced by ethanol administration in rat, the ulcerogenic effect of chronic alcohol administration (3.03 g/kg b.w. or 7.28 g/kg b.w.) given in drinking water, producing liver lesions and portal hypertension, is fa…
Animal Study
PMID: 11595453
Journal of physiology, Paris|2001|Stancic-Rokotov D et al.
Hemorrhagic mucosal lesions in the stomach in the rat induced by an intragastrical application of 1 ml of 50 or 75% ethanol were aggravated by preceding lung damage provoked by an intratracheal instillation of pyrogen-free saline or HCl (pH 1.75) or…
Animal Study
PMID: 11595452
Journal of physiology, Paris|2001|Sikiric P et al.
After demonstration that cysteamine induced duodenal lesions in gastrectomized rats, while a number of antiulcer drugs mitigated these lesions, it was shown that one single intrarectal (i.r.) cysteamine application produced severe colon lesions in ac…
Animal Study
PMID: 11595451
Life sciences|2001|Bilic I et al.
The focus was on haloperidol (central dopamine antagonist)-stomach lesion, a longly described suitable counterpart of dopamine blocker cysteamine-duodenal lesion. In this, the contribution of blockade of central/peripheral dopamine receptors and pros…
Animal Study
PMID: 11292068
Journal of physiology, Paris|2001|Sikiric P et al.
Recently, we showed cysteamine-duodenal lesions without gastric acid, since they were induced also in gastrectomized rats, as in naive rats, and they were inhibited by the novel stomach pentadecapeptide BPC 157 as well as standard antiulcer drugs (i.…
Animal Study
PMID: 11595448
Acta pharmacologica Sinica|2001|Sikiric P et al.
AIM: To study anxiolytic effect of a gastric pentadecapeptide, BPC-157. METHODS: In shock probe/burying test, pentadecapeptide BPC-157 (10 microg/kg, 10 ng/kg, ip), diazepam (0.075, 0.0375 mg/kg, ip), and an equivolume of saline (5 mL/kg, ip) were gi…
Animal Study
PMID: 11742568
Burns : journal of the International Society for Burn Injuries|2001|Mikus D et al.
The effects of the gastric pentadecapeptide BPC 157 were investigated when administered topically or systemically in burned mice. This agent is known to have a beneficial effect in a variety of models of gastrointestinal lesions, as well as on wound…
Animal Study
PMID: 11718984
Journal of physiology, Paris|2001|Prkacin I et al.
Liver lesions and portal hypertension in rats, following chronic alcohol administration, are a particular target for therapy. Portal hypertension (mm Hg) assessed directly into the portal vein, and liver lesions induced by 7.28 g/kg b.w. of alcohol g…
Animal Study
PMID: 11595456
Journal of physiology, Paris|2000|Sikiric P et al.
Up to now, for gastric lesions potentiation or induction, as well as determination of endogenous dopamine significance, dopamine antagonist or dopamine vesicle depletor were given separately. Therefore, without combination studies, the evidence for d…
Animal Study
PMID: 10791690
Journal of physiology, Paris|2000|Sikiric P et al.
Various antidepressants have antiulcer activity. Likewise, the models currently used in ulcers and depression disorders research have a considerable degree of similarity. Therefore, the possibility that depression disorders could be effectively influ…
Animal Study
PMID: 10791689
Inflammopharmacology|1999|Sikiric P
The reported beneficial effects of the gastric mucosal derived pentadecapeptide BPC 157 (Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val, M.W. 1419) on different organ lesions are reviewed. Apart from the effects on various gastrointestin…
PMID: 17657443
The Chinese journal of physiology|1999|Jelovac N et al.
A novel gastric pentadecapeptide BPC 157 with different beneficial activities and anticonvulsant effect interacting with GABAergic system could improve diazepam efficacy coadministered (10 microg/kg, 10 ng/kg i.p.) with diazepam (5.0 mg/kg i.p.) twic…
Animal Study
PMID: 10707891
Journal of physiology, Paris|1999|Sikiric P et al.
The effect of a stomach pentadecapeptide, BPC 157, on Parkinson's disease in mice was investigated, along with its salutary activity on stomach lesions induced by parkinsongenic agents. Parkinsongenic agents, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid…
Animal Study
PMID: 10672997
Journal of physiology, Paris|1999|Petek M et al.
A diabetogenic alloxan regimen produced lesions in all stomachs of treated animals, either rats (200 mg x kg(-1) s.c.) or mice (400 mg x kg(-1) i.p.). In control animals, the lesions, when developed (i.e. 24 h following application), appear to be qui…
Animal Study
PMID: 10672996